Quick Answer
Evolent Health, Inc. reported Long Term Debt of $970.54 million for the year ending 2025.
- Evolent Health, Inc. showed an increase of +97.9% in Long Term Debt from 2024 to 2025.
- This data is from Evolent Health, Inc.'s annual report (Form 10-K), filed with the SEC on February 25, 2026.
- XBRL data for this metric is available from 2015 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2017: $120.71 million | Q2 2017: $120.94 million | Q3 2017: $121.16 million | Q1 2018: $121.62 million | Q2 2018: $121.85 million | Q3 2018: $122.08 million | Q1 2019: $223.32 million | Q2 2019: $225.64 million | Q3 2019: $228.00 million | Q4 2019: $293.67 million | Q1 2020: $296.68 million | Q2 2020: $299.75 million | Q3 2020: $285.21 million | Q1 2021: $202.13 million | Q2 2021: $206.55 million | Q3 2021: $211.06 million | Q1 2022: $282.60 million | Q2 2022: $283.14 million | Q3 2022: $412.44 million | Q1 2023: $632.28 million | Q2 2023: $633.01 million | Q3 2023: $599.95 million | Q1 2024: $597.90 million | Q2 2024: $598.78 million | Q3 2024: $599.67 million | Q1 2025: $647.53 million | Q2 2025: $648.46 million | Q3 2025: $1.05 billion.
- Historical annual values: Fiscal year 2025: $970.54 million | Fiscal year 2024: $490.52 million | Fiscal year 2023: $597.05 million | Fiscal year 2022: $412.99 million | Fiscal year 2021: $215.68 million | Fiscal year 2020: $263.34 million | Fiscal year 2019: $293.67 million | Fiscal year 2019: $293.67 million | Fiscal year 2018: $221.04 million | Fiscal year 2017: $121.39 million | Fiscal year 2016: $120.28 million | Fiscal year 2015: $0.00.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: